Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Haw Par Corporation Limited

HAWPY•PNK
Healthcare
Drug Manufacturers - General
$49.03
$0.00(0.00%)
U.S. Market opens in 8h 20m

Haw Par Corporation Limited (HAWPY) Stock Overview

Explore Haw Par Corporation Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.7B
P/E Ratio13.73
EPS (TTM)$3.58
ROE0.06%
Fundamental Analysis

AI Price Forecasts

1 Month$53.56
3 Months$58.65
1 Year Target$57.90

HAWPY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Haw Par Corporation Limited (HAWPY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 46.39, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $57.90.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 13.73 and a market capitalization of 2.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-3.48%
6-Month Change
-3.48%
Year-to-Date (YTD) Change
-3.48%
1-Year Change
71.19%
3-Year Change
71.19%
5-Year Change
77.64%
All-Time (Max) Change
90.26%

Contact Information

https://www.hawpar.com
65 6337 9102
No. 03-03 Haw Par Technocentre, Singapore, NaN, 149598

Company Facts

IPO DateApr 3, 2013
CountrySG
Actively Trading

Frequently Asked Questions